What is menthol methyl salicylate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Menthol Methyl Salicylate: Definition and Clinical Applications

Menthol methyl salicylate is a combination topical analgesic product containing menthol (a cooling compound that activates TRPM8 receptors) and methyl salicylate (a salicylate derivative with anti-inflammatory properties), commonly found in over-the-counter products like Bengay and Icy Hot for musculoskeletal pain relief. 1

Component Pharmacology

Menthol

  • Acts as a topical cooling compound that selectively activates TRPM8 receptors, which are upregulated after sensory nerve injury 1
  • Produces cooling, counterirritant, and analgesic properties through activation of sensory nerve receptors in the nose, mouth, and airway 1
  • Induces cold response signals by rapidly increasing intracellular calcium and mobilizing calcium flux through ion channels 2
  • Demonstrates cutaneous vasodilation effects with peak microcirculation increases occurring within 5 minutes of application 3

Methyl Salicylate

  • A concentrated, lipid-soluble salicylate derivative (oil of wintergreen) that provides anti-inflammatory effects through topical application 4
  • Demonstrates significant reduction in pro-inflammatory gene expression (TNFα, IL1α, IL6, IL8, NFKβ) ranging from -39% to -92.6% compared to controls 5
  • Approximately 0.8% of applied methyl salicylate penetrates the skin with time-dependent concentration increases 5
  • Systemic absorption occurs with plasma concentrations reaching 29.5 ± 10.5 ng/mL after 8-patch application for 8 hours 6

Clinical Applications

Approved Uses

  • Symptomatic relief of musculoskeletal aches and pains in osteoarthritis and other joint conditions 1
  • Temporary pain relief during chemotherapy-induced peripheral neuropathy (CIPN), though requiring further study 1
  • Management of erythromelalgia symptoms during acute flares 1

Evidence for Efficacy

  • For CIPN: Phase II trial showed 83% of patients demonstrated pain improvement after 4-6 weeks with 1% topical menthol 1
  • A second open-label study reported 75% of subjects had ≥10% decrease and 50% showed >30% decrease in self-reported CIPN symptoms 1
  • For musculoskeletal pain: Demonstrates anti-inflammatory effects lasting up to 12 hours post-application 5

Critical Safety Considerations

ABSOLUTE CONTRAINDICATIONS

  • Children under 2 years of age: Strictly contraindicated due to risk of life-threatening systemic salicylate toxicity 7, 8
  • Children under 12 years with viral illnesses (influenza, varicella): Risk of Reye syndrome 8
  • Never apply to more than 20% of body surface area to avoid systemic toxicity 8

High-Risk Populations

  • Children under 12 years have significantly increased risk due to higher body-surface-to-mass ratio leading to greater systemic absorption 7, 8
  • Patients receiving warfarin therapy: Risk of adverse interactions and bleeding complications 4
  • Patients with impaired renal function: Lower threshold for salicylate toxicity 9

Adverse Effects

  • Irritant or allergic contact dermatitis and anaphylactic reactions possible 4
  • Rapid-onset salicylate poisoning if ingested due to liquid, concentrated form and lipid solubility 4
  • Potential for rebound erythema with continued use 1

Practical Application Guidelines

Dosing and Administration

  • Apply to affected areas 3-4 times daily as needed 1
  • Limit treatment area strictly when used in children (if absolutely necessary and >2 years old) 8
  • Avoid occlusive dressings which may increase systemic absorption 6

Monitoring Requirements

  • If signs of salicylate toxicity develop (altered mental status, tinnitus, hyperventilation): Monitor arterial blood gases and serum salicylate levels 9
  • Blood pH ≤7.20 indicates need for extracorporeal treatment 9
  • Watch for CNS symptoms indicating severe toxicity and increased CNS penetration 9

Common Pitfalls to Avoid

  • Underestimating chronic toxicity risk: Patients with chronic exposure may have lower serum levels but more severe symptoms 9
  • Combining with oral salicylate medications: Creates additive systemic effects and increased toxicity risk 8
  • Using in children with undiagnosed fever or viral illness: May precipitate Reye syndrome 8
  • Applying to large body surface areas: Dramatically increases systemic absorption 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Menthol--pharmacology of an important naturally medicinal "cool".

Mini reviews in medicinal chemistry, 2013

Guideline

Molluscum Contagiosum Treatment Considerations in Young Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Methyl Salicylate Toxicity in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Laboratory Monitoring for Salicylate Toxicity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the active ingredient in Bengay (methyl salicylate and menthol)?
What are the contraindications for using the Salonpas (methyl salicylate and menthol) patch in patients with various medical conditions, including impaired renal (kidney) function, liver disease, asthma, or sensitive skin?
How many times a day can you apply Biofreeze (methyl salicylate)?
Is Bengay (methyl salicylate) effective for leg stiffness?
Is it safe to apply BenGay (methyl salicylate) to the neck in an adult patient with no known allergies or sensitivities?
Which of the following statements about the pharmacologic treatment of chronic obstructive pulmonary disease (COPD) are correct? a) improves forced expiratory volume in one second (FEV1) b) reduces the frequency and severity of exacerbations c) improves quality of life d) increases patient survival e) improves exercise capacity
What are the appropriate next steps for a 34‑year‑old woman with Ehlers‑Danlos syndrome, mast‑cell activation syndrome, postural orthostatic tachycardia syndrome, low‑normal immunoglobulin A and G, recurrent ear and respiratory infections, and non‑immune measles and mumps despite two childhood MMR doses?
How far inferior to the orbital rim should the dissection be performed when freeing the premaxillary and prezygomatic spaces?
How should I manage a 5-year-old with a foreign body in the external auditory canal?
How should constipation be evaluated and managed in a patient with diabetes?
What is the recommended outpatient treatment for walking (atypical) pneumonia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.